MAPT and supranuclear palsy, progressive, 1: However, due to the variability of tau cytopathologies and clinical phenotypes, a staging system such as that developed focusing only on neuronal protein depositions exemplified by neurofibrillary tangles [3] or Lewy bodies [4] has not yet been proposed for PSP.